Paul A. Levine, MD, FACS
Robert W. Cantrell Professor and Chairman, Director, Division of Head and Neck Surgical Oncology
Born in Brooklyn, New York on November 4, 1947, Paul A. Levine, MD received a Bachelor of Science degree in Biology from Rensselaer Polytechnic Institute in 1969, his M.D. from Albany Medical College in 1973, and completed his internship and otolaryngology-head and neck surgery surgical residency at Yale in 1977. After a year fellowship at Stanford in head and neck, maxillofacial, and facial plastic and reconstructive surgery completed in 1978, Dr. Levine remained on the Stanford faculty as an assistant professor in the Division of Otolaryngology-Head and Neck Surgery as well as the associate chief for the Division at Santa Clara Valley Medical Center. In 1984, he joined the Department of Otolaryngology-Head and Neck Surgery at the University of Virginia as an associate professor and vice chair, became a tenured professor in 1987, and was named chairman of the department at UVA in 1997, a position he stills holds.
Dr. Levine has contributed over 140 publications to the specialty during his career and has been very active in institutional and national committees in and outside the specialty throughout his career. He was an early proponent of plate fixation for mandible fractures, and he has become recognized for his expertise in treating sinonasal malignancies, especially esthesioneuroblastoma and sinonasal undifferentiated carcinoma, as well as experience in performing craniofacial resections and sparing of the eye when treating these malignancies. A nationally and internationally recognized academic head and neck cancer surgeon, Dr. Levine has served as a member of all the major societies in the field and as a leader of many. He has served as the past president of the American Broncho-Esophagological Association, chairman of the Advanced Training Council of the American Head and Neck Society as well as the President of the AHNS. He has been a director of the American Board of Otolaryngology, completing his 12 year term in 2010, and served as its treasurer for four years. He completed his term as Southern Section Vice President of the Triological Society in 2007 and currently serves as the editor of Archives of Otolaryngology-Head and Neck Surgery as well as an editorial board member of JAMA.
Outcomes of patients with head-and-neck cancer of unknown primary origin treated with intensity-modulated radiotherapy. Shoushtari A, Saylor D, Kerr KL, Sheng K, Thomas C, Jameson M, Reibel J, Shonka D, Levine P, Read P. Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):e83-91. Epub 2011 Mar 4.
Immediate postoperative extubation in patients undergoing free tissue transfer. Allak A, Nguyen TN, Shonka DC Jr, Reibel JF, Levine PA, Jameson MJ. Laryngoscope. 2011 Apr;121(4):763-8. doi: 10.1002/lary.21397.
Intensity-modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status. Shoushtari A, Meeneghan M, Sheng K, Moskaluk CA, Thomas CY, Reibel JF, Levine PA, Jameson MJ, Keene K, Read PW. Cancer. 2010 Jun 1;116(11):2645-54.
Clinical nodal staging of T1-2 tonsillar squamous cell carcinoma stratified by p16 status and implications for ipsilateral neck irradiation. Shoushtari AN, Meeneghan M, Treharne GC, Reibel JF, Levine PA, Moskaluk CA, Jameson MJ, Read PW. Cancer J. 2010 May-Jun;16(3):284-7.
Predicting residual neck disease in patients with oropharyngeal squamous cell carcinoma treated with radiation therapy: utility of p16 status. Shonka DC Jr, Shoushtari AN, Thomas CY, Moskaluk C, Read PW, Reibel JF, Levine PA, Jameson MJ. Arch Otolaryngol Head Neck Surg. 2009 Nov;135(11):1126-32.